Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (181-190 of 768) with videos related to

Pageof 77
Sort By:
Blood|January 1, 1995
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantationR L Paquette, N Tebyani, M Frane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 22, 2018
Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective studyElla J Ariza-Heredia, Roy F Chemaly, Lokesh R Shahani, et al.
Transplantation Proceedings|December 1, 1992
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphomaD Przepiorka, S Giralt, Y O Huh, et al.
Bone Marrow Transplantation|April 1, 1994
Influenza A virus infections among hospitalized adult bone marrow transplant recipientsE Whimbey, L S Elting, R B Couch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic MalignanciesStefan O Ciurea, Piyanuch Kongtim, Omar Hasan, et al.
Experimental Hematology|August 14, 2018
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cellsBenigno C Valdez, Xiaowen Tang, Yang Li, et al.
Clinical Pharmacy|July 1, 1993
Adverse effects of molgramostim in marrow transplant recipientsC Ippoliti, D Przepiorka, T Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantationKazutaka Nakayama, Nizar M Tannir, Ping Liu, et al.
Experimental Hematology|February 24, 2015
Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulatorsBenigno C Valdez, Yang Li, David Murray, et al.
The New England Journal of Medicine|March 8, 2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cellsMartin Körbling, Ruth L Katz, Abha Khanna, et al.
Pageof 77

Showing results (181-190 of 768) with videos related to

Sort By:
Pageof 77
Blood|January 1, 1995
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantationR L Paquette, N Tebyani, M Frane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 22, 2018
Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective studyElla J Ariza-Heredia, Roy F Chemaly, Lokesh R Shahani, et al.
Transplantation Proceedings|December 1, 1992
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphomaD Przepiorka, S Giralt, Y O Huh, et al.
Bone Marrow Transplantation|April 1, 1994
Influenza A virus infections among hospitalized adult bone marrow transplant recipientsE Whimbey, L S Elting, R B Couch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic MalignanciesStefan O Ciurea, Piyanuch Kongtim, Omar Hasan, et al.
Experimental Hematology|August 14, 2018
Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cellsBenigno C Valdez, Xiaowen Tang, Yang Li, et al.
Clinical Pharmacy|July 1, 1993
Adverse effects of molgramostim in marrow transplant recipientsC Ippoliti, D Przepiorka, T Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantationKazutaka Nakayama, Nizar M Tannir, Ping Liu, et al.
Experimental Hematology|February 24, 2015
Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulatorsBenigno C Valdez, Yang Li, David Murray, et al.
The New England Journal of Medicine|March 8, 2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cellsMartin Körbling, Ruth L Katz, Abha Khanna, et al.
Pageof 77